8-KThe WireRed Alert
Executive Change · Results of Operations
Filed Apr 30, 2026 · 2mo ago · Accession 0001104659-26-053102
Plain English
TELA Bio, Inc. announced preliminary first quarter 2026 revenue and a significant change in its Board of Directors, including the resignation of the Chairman and other directors, and the appointment of new directors.
Filing details
- Company
- TELA Bio, Inc.
- Ticker
- TELA
- CIK
- 1561921
- Form type
- 8-K
- Filing date
- Apr 30, 2026
- Report date
- Apr 29, 2026
- Document
- tm2612982d1_8k.htm
- Size
- 204 KB